Skip to main content

Duke Cancer Institute

DCI Blog
Events
DCI Members
Contact
Give

Cancer Types and Programs

Primary Brain Cancer
Brain and Spine Metastasis
Breast Cancer
Endocrine Neoplasia
Gastrointestinal Cancer
Gynecologic Cancer
Head and Neck Cancer
Hematologic Malignancies and Cellular Therapy
Immunotherapy
Melanoma and Advanced Skin Cancers
Molecular Tumor Board
Pediatric Cancers
Prostate and Urologic Cancers
Sarcoma
Thoracic Cancer

Supportive Care

Supportive Care and Survivorship Center

Research

Cancer Registry
Clinical Trials
Research Programs
Shared Resources

Education and Training

Office of Cancer Research Training and Education Coordination

About DCI

DCI Overview
DCI Members
Nursing
Careers
Community Outreach, Engagement, and Equity
Contact
DCI blog
Events

Get Involved

Giving Opportunities
Benefits and Special Events
Breakthroughs Magazine

Make an Appointment

Blogs

AI-Driven Biomarker Predicts Optimum Length of Treatment for Prostate Cancer

Published

June 01, 2023

Written By

Sarah Avery

Director, Duke Health News Office

Topics

Center for Prostate and Urologic Cancers
Prostate Cancer
Research

Share

Share This Page

Print Page Or Copy Link Url

Copied to clipboard

Related News

Duke Oncologist Discusses Former President Biden’s Prostate Cancer Diagnosis

May 19, 2025

CBS17

‘Don’t Sit in a Cave’: NC Man Urges Importance of Screenings After Biden’s Prostate Cancer Diagnosis

May 19, 2025

WRAL-TV NBC Raleigh

Related News

Duke Oncologist Discusses Former President Biden’s Prostate Cancer Diagnosis

May 19, 2025

CBS17

‘Don’t Sit in a Cave’: NC Man Urges Importance of Screenings After Biden’s Prostate Cancer Diagnosis

May 19, 2025

WRAL-TV NBC Raleigh

Website Privacy Policy
Sitemap
Leading with Heart: Serving Humanity
Notice of Nondiscrimination
Notice of Privacy Practices
Terms and Conditions
Accessibility
© DUKE CANCER INSTITUTE 2025

Back to Top